These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

375 related articles for article (PubMed ID: 24457276)

  • 21. Primary coronary microvascular dysfunction and poor coronary collaterals predict post-percutaneous coronary intervention cardiac necrosis.
    Hoole SP; White PA; Heck PM; Khan SN; Densem CG; Clarke SC; Shapiro LM; Schofield PM; O'Sullivan M; Dutka DP
    Coron Artery Dis; 2009 Jun; 20(4):253-9. PubMed ID: 19440064
    [TBL] [Abstract][Full Text] [Related]  

  • 22. Intravenous administration of nicorandil immediately before percutaneous coronary intervention can prevent slow coronary flow phenomenon.
    Kawai Y; Hisamatsu K; Matsubara H; Dan K; Akagi S; Miyaji K; Munemasa M; Fujimoto Y; Kusano KF; Ohe T
    Eur Heart J; 2009 Apr; 30(7):765-72. PubMed ID: 19276198
    [TBL] [Abstract][Full Text] [Related]  

  • 23. Effects of mitochondrial ATP-sensitive potassium channel activation (nicorandil) in patients with angina pectoris undergoing elective percutaneous coronary interventions: A meta-analysis of randomized controlled trials.
    Zhu H; Xu X; Fang X; Zheng J; Chen T; Huang J
    Medicine (Baltimore); 2019 Jan; 98(3):e14165. PubMed ID: 30653160
    [TBL] [Abstract][Full Text] [Related]  

  • 24. Nicorandil reduces the incidence of minor cardiac marker elevation after coronary stenting.
    Murakami M; Iwasaki K; Kusachi S; Hina K; Hirota M; Hirohata S; Kamikawa S; Sangawa M; Yamamoto K; Shiratori Y
    Int J Cardiol; 2006 Feb; 107(1):48-53. PubMed ID: 16337497
    [TBL] [Abstract][Full Text] [Related]  

  • 25. Effect of intravenous nicorandil and preexisting angina pectoris on short- and long-term outcomes in patients with a first ST-segment elevation acute myocardial infarction.
    Ishii H; Ichimiya S; Kanashiro M; Amano T; Ogawa Y; Mitsuhashi H; Sakai S; Uetani T; Murakami R; Naruse K; Murohara T; Matsubara T
    Am J Cardiol; 2007 May; 99(9):1203-7. PubMed ID: 17478142
    [TBL] [Abstract][Full Text] [Related]  

  • 26. Cardioprotective effects of single oral dose of nicorandil before selective percutaneous coronary intervention.
    Yang J; Zhang J; Cui W; Liu F; Xie R; Yang X; Gu G; Zheng H; Lu J; Yang X; Zhang G; Wang Q; Geng X
    Anatol J Cardiol; 2015 Feb; 15(2):125-31. PubMed ID: 25252296
    [TBL] [Abstract][Full Text] [Related]  

  • 27. Myocardial protective effects of nicorandil during percutaneous coronary intervention in patients with unstable angina.
    Kim JH; Jeong MH; Yun KH; Kim KH; Kang DK; Hong SN; Lim SY; Lee SH; Lee YS; Hong YJ; Park HW; Kim W; Ahn YK; Cho JG; Park JC; Kang JC
    Circ J; 2005 Mar; 69(3):306-10. PubMed ID: 15731536
    [TBL] [Abstract][Full Text] [Related]  

  • 28. Effect of myocardial protection of intracoronary adenosine and nicorandil injection in patients undergoing non-urgent percutaneous coronary intervention: a randomized controlled trial.
    Kim SJ; Kim W; Woo JS; Ha SJ; Kang WY; Hwang SH; Kang DG; Lee SU; Cho SK; Im JS; Kim W
    Int J Cardiol; 2012 Jun; 158(1):88-92. PubMed ID: 21256606
    [TBL] [Abstract][Full Text] [Related]  

  • 29. Effect of nicorandil administration on cardiac burden and cardio-ankle vascular index after coronary intervention.
    Sato S; Takahashi M; Mikamo H; Kawazoe M; Iizuka T; Shimizu K; Noro M; Shirai K
    Heart Vessels; 2020 Dec; 35(12):1664-1671. PubMed ID: 32572567
    [TBL] [Abstract][Full Text] [Related]  

  • 30. Utility of nicorandil for the measurement of coronary fractional flow reserve.
    Oi M; Toyofuku M; Matsumura Y; Motohashi Y; Takahashi K; Kawase Y; Ko E; Tanaka M; Kitada M; Yuzuki Y; Tamura T; Tanaka N; Kimura T
    Cardiovasc Interv Ther; 2014 Jan; 29(1):24-30. PubMed ID: 24002893
    [TBL] [Abstract][Full Text] [Related]  

  • 31. Effects of Danhong Injection () on Peri-Procedural Myocardial Injury and Microcirculatory Resistance in Patients with Unstable Angina Undergoing Elective Percutaneous Coronary Intervention: A Pilot Randomized Study.
    Xing WL; Wu YJ; Liu HX; Liu QR; Zhou Q; Li AY; Zhang ZH; Li X
    Chin J Integr Med; 2021 Nov; 27(11):846-853. PubMed ID: 34263442
    [TBL] [Abstract][Full Text] [Related]  

  • 32. Efficacy of oral nicorandil in patients with end-stage renal disease: a retrospective chart review after coronary angioplasty in Japanese patients receiving hemodialysis.
    Ishii H; Toriyama T; Aoyama T; Takahashi H; Yamada S; Kasuga H; Ichimiya S; Kanashiro M; Mitsuhashi H; Maruyama S; Matsuo S; Naruse K; Matsubara T; Murohara T
    Clin Ther; 2007 Jan; 29(1):110-22. PubMed ID: 17379051
    [TBL] [Abstract][Full Text] [Related]  

  • 33. The periprocedural myocardial damage prevention during elective percutaneous coronary intervention as a result of pharmacological preconditioning with an oral form of nicorandil in patients with stable coronary artery disease. Pilot study.
    Gostishchev RV; Soboleva GN; Samko AN; Rogoza AN; Minasyan AA
    Ter Arkh; 2018 Sep; 90(9):53-59. PubMed ID: 30701736
    [TBL] [Abstract][Full Text] [Related]  

  • 34. Cardioprotective effects of oral nicorandil use in diabetic patients undergoing elective percutaneous coronary intervention.
    Shehata M
    J Interv Cardiol; 2014 Oct; 27(5):472-81. PubMed ID: 25174952
    [TBL] [Abstract][Full Text] [Related]  

  • 35. How does coronary stent implantation impact on the status of the microcirculation during primary percutaneous coronary intervention in patients with ST-elevation myocardial infarction?
    De Maria GL; Cuculi F; Patel N; Dawkins S; Fahrni G; Kassimis G; Choudhury RP; Forfar JC; Prendergast BD; Channon KM; Kharbanda RK; Banning AP
    Eur Heart J; 2015 Dec; 36(45):3165-77. PubMed ID: 26254178
    [TBL] [Abstract][Full Text] [Related]  

  • 36. Influence of percutaneous coronary intervention on coronary microvascular resistance index.
    Verhoeff BJ; Siebes M; Meuwissen M; Atasever B; Voskuil M; de Winter RJ; Koch KT; Tijssen JG; Spaan JA; Piek JJ
    Circulation; 2005 Jan; 111(1):76-82. PubMed ID: 15611371
    [TBL] [Abstract][Full Text] [Related]  

  • 37. Impact of long-term statin therapy on postprocedural myocardial infarction in patients undergoing nonemergency percutaneous coronary intervention.
    Gordin J; Haider A; Swaminathan RV; Kim LK; Minutello RM; Bergman G; Wong SC; Feldman DN
    Am J Cardiol; 2012 Nov; 110(10):1397-404. PubMed ID: 22858186
    [TBL] [Abstract][Full Text] [Related]  

  • 38. Design and Rationale for the Endothelin-1 Receptor Antagonism in the Prevention of Microvascular Injury in Patients with non-ST Elevation Acute Coronary Syndrome Undergoing Percutaneous Coronary Intervention (ENDORA-PCI) Trial.
    Liou K; Jepson N; Buckley N; Chen V; Thomas S; Russell EA; Ooi SY
    Cardiovasc Drugs Ther; 2016 Apr; 30(2):169-75. PubMed ID: 26814686
    [TBL] [Abstract][Full Text] [Related]  

  • 39. Relationship between subclinical cardiac troponin I elevation and culprit lesion characteristics assessed by optical coherence tomography in patients undergoing elective percutaneous coronary intervention.
    Lee T; Murai T; Yonetsu T; Suzuki A; Hishikari K; Kanaji Y; Matsuda J; Araki M; Niida T; Isobe M; Kakuta T
    Circ Cardiovasc Interv; 2015 Apr; 8(4):. PubMed ID: 25829198
    [TBL] [Abstract][Full Text] [Related]  

  • 40. Target lesion thin-cap fibroatheroma defined by virtual histology intravascular ultrasound affects microvascular injury during percutaneous coronary intervention in patients with angina pectoris.
    Yamada R; Okura H; Kume T; Neishi Y; Kawamoto T; Miyamoto Y; Imai K; Saito K; Tsuchiya T; Hayashida A; Yoshida K
    Circ J; 2010 Aug; 74(8):1658-62. PubMed ID: 20595776
    [TBL] [Abstract][Full Text] [Related]  

    [Previous]   [Next]    [New Search]
    of 19.